Nov 04, 2019 / 01:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Halozyme update call.
(Operator Instructions)
Please be advised that today's conference is being recorded.
(Operator Instructions)
I'd now like to hand the conference over to your speaker today, Al Kildani, Vice President of Investor Relations and Corporate Communications. Please go ahead, sir.
Albert S. Kildani - Halozyme Therapeutics, Inc. - VP of IR & Corporate Communications
Good morning, and welcome to our call. Please refer to the 2 press releases issued by the company this morning for today's call. Leading the call will be Dr. Helen Torley, Halozyme's President and Chief Executive Officer. Also on the call for the Q&A portion is Laurie Stelzer, our Chief Financial Officer.
During the call, we will be making forward-looking statements. I refer you to our SEC filings for a full listing of the risks and uncertainties.
I'll now turn the call over to Helen.
Helen I. Torley - Halozyme Therapeutics,
Halozyme Therapeutics Inc Call to Discuss Plans to Focus Strategy on ENHANZE® Drug Delivery Technology Transcript
Nov 04, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers